Simultaneous quantitative analysis of mebendazole polymorphs A-C in powder mixtures by DRIFTS spectroscopy and ANN modeling

Journal of Pharmaceutical and Biomedical Analysis

Volumn 51, Issue 3, 2010, Pages 512-520

  Kachrimanis, K ^a   Rontogianni, M ^a   Malamataris, S ^a  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

Author keywords

Artificial neural networks; Crystal polymorphism; FTIR spectroscopy; Mebendazole; Partial least squares regression; Quantitative analysis

Indexed keywords

MEBENDAZOLE;

ARTICLE; ARTIFICIAL NEURAL NETWORK; CONTROLLED STUDY; DIFFUSE REFLECTANCE SPECTROSCOPY; DRUG STRUCTURE; INFRARED SPECTROSCOPY; PARTIAL LEAST SQUARES REGRESSION; POWDER; PREDICTION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; QUANTUM CHEMISTRY; SPECTROSCOPY; STRUCTURE ANALYSIS;

CRYSTALLIZATION; EVALUATION STUDIES AS TOPIC; MEBENDAZOLE; NEURAL NETWORKS (COMPUTER); POWDERS; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; SUSPENSIONS;

EID: 70350608141     PISSN: 07317085     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpba.2009.09.001     Document Type: Article

References (38)

1. Raeymackers A., Van Gelder J., Roevens L., and Janssen P. Synthesis and anthelminthic activity of alkyl-(5-acyl-1-benzimidazol-2-yl) carbamates. Arzneim.-Forsch./Drug Res. 28 (1978) 586-594
2. Mukhopadhyay T., Sasaki J., Ramesh R., and Roth J. Mebendazole elicits a potent antitumor effect on human cancer cell lines both in vitro and in vivo. Clin. Cancer Res. 8 (2002) 2963-2969
3. European Pharmacopoeia, 5th edition, Monographs, Council of Europe, cop. Strasbourg, 2008, pp. 1981-1982.
4. Himmelreich M., Rawson B.J., and Watson T.R. Polymorphic forms of mebendazole. Aust. J. Pharm. Sci. 6 (1977) 123-125
5. Costa J., Fresno M., Guzman L., Igual A., Oliva J., Vidal P., Perez A., and Pujol M. Polymorphic forms of mebendazole: analytical aspects and toxicity. Circ. Farm. 49 (1991) 415-424
6. Ren H., Luo K.J., and Cheng B.Z. Effects of various anti-hookworm drugs on the cholinesterase activity of Necator americanus, Ancylostoma duodenale, Ancylostoma caninum and Nippostrongylus braziliensis. Chin. J. Parasitol. Parasit. Dis. 5 (1987) 13-17
7. Charoenlarp P., Waikagul J., Muennoo C., Srinophakun S., and Kitayaporn D. Efficacy of single-dose mebendazole, polymorphic forms A and C, in the treatment of hookworm and Trichuris infections. J. Trop. Med. Publ. Health 24 (1993) 712-716
8. Rodriguez-Caabeiro F., Criado-Fornelio A., Jimenez-Conzalez A., Guzman L., Igual A., Perez A., and Pujol M. Experimental chemotherapy and toxicity in mice of three mebendazole polymorphic forms. Chemotherapy 33 (1987) 266-271
9. Liebenberg W., Dekker T.G., Lötter A.P., and de Villiers M.M. Identification of the mebendazole polymorphic form present in raw materials and tablets available in South Africa. Drug Dev. Ind. Pharm. 24 (1998) 485-488
10. Agatonovic-Kustrin S., Glass B., Mangan M., and Smithson J. Analysing the crystal purity of mebendazole raw material and its stability in a suspension formulation. Int. J. Pharm. 361 (2008) 245-250
11. Froelic P., and Gasparotto F. Mebendazole: identification of polymorphs of the drug in several different bulk substances and dosage forms (reference brand and generic) available in Brazil. Rev. Sci. Farm. Basica Aplicada 26 (2005) 205-210
12. de Villiers M., Terblanche R., Liebenberg W., Swanepoel E., Dekker T., and Song M. Variable-temperature X-ray powder diffraction analysis of the crystal transformation of the pharmaceutically preferred polymorph C of mebendazole. J. Pharm. Biomed. Anal. 38 (2005) 435-441
13. Sha Z., Sun W., and Gao H. Infrared spectrometry determination of polymorphic form C in mebendazole. Yaoxue Xuebao Acta Pharm. Sinica 24 (1989) 932-936
14. B. Glass, S. Agatonovic-Kustrin, M. Brown, M. Mangan, E. Mopp, M. Aereboe, Analyzing the crystal purity of mebendazole raw material by DRIFT spectrometry and ANN spectral modelling, in: 7th International Conference/Workshop on Pharmacy and Applied Physical Chemistry Phandta 7 Innsbruck, Austria, September 07-11, 2003.
15. Bunaciu A., Fleschin S., and Aboul-Enein H.Y. Analysis of mebendazole polymorphs by Fourier transform infrared spectrometry using chemometric methods. Spectrosc. Lett. 34 (2001) 527-536
16. Aboul-Enein H., Bunaciu A., and Fleschin S. Analysis of mebendazole polymorphs by Fourier transform IR spectrometry using chemometric methods. Biopolymers (Biospectroscopy) 67 (2002) 56-60
17. Pecharroman C., and Iglesias J. Effect of particle shape on the IR reflectance spectra of pressed powders of anisotropic materials. Appl. Spectrosc. 54 (2000) 634-638
18. Kipouros K., Kachrimanis K., Nikolakakis I., Tserki V., and Malamataris S. Simultaneous quantification of carbamazepine crystal forms in ternary mixtures (I, III, and IV) by diffuse reflectance FTIR spectroscopy (DRIFTS) and multivariate calibration. J. Pharm. Sci. 95 (2006) 2419-2431
19. Kachrimanis K., Braun D.E., and Griesser U.J. Quantitative analysis of paracetamol polymorphs in powder mixtures by FT-Raman spectroscopy and PLS regression. J. Pharm. Biomed. Anal. 43 (2007) 407-412
20. Madari B., Reeves III J., Machado P., Guimaraes C., Torres E., and McCarthy G. Mid- and near-infrared spectroscopic assessment of soil compositional parameters and structural indices in two Ferralsols. Geoderma 136 (2006) 245-259
21. Trask A., Motherwell W., and Jones W. Solvent-drop grinding: green polymorph control of cocrystallisation. Chem. Commun. 7 (2004) 890-891
22. Kennard R., and Stone L. Computer aided design of experiments. Technometrics 11 (1969) 137-148
23. Wu W., Walczak B., Massart D.L., Heuerding S., Erni F., Last I., and Prebble K. Artificial neural networks in classification of NIR spectral data: design of the training set. Chemom. Int. Lab. Syst. 33 (1996) 35-46
24. Daszykowski M., Walczak B., and Massart D.L. Representative subset selection. Anal. Chim. Acta 468 (2002) 91-103
25. Westerhuis J., de Jong S., and Smilde A. Direct orthogonal signal correction. Chemom. Intell. Lab. Syst. 56 (2001) 13-25
26. Gorry P. General least-squares smoothing and differentiation by the convolution (Savitzky-Golay) method. Anal. Chem. 62 (1990) 570-573
27. Nabney I. Netlab: Algorithms for Pattern Recognition. Advances in Pattern Recognition (2001), Springer
28. Kumar S., Chawla G., Sobhia M.E., and Bansal A.K. Characterization of solid-state forms of mebendazole. Pharmazie 63 (2008) 136-143
29. Baker J., Kessi A., and Delley B. The generation and use of delocalized internal coordinates. J. Chem. Phys. 105 (1996) 192-212
30. Becke A. Density-functional thermochemistry. III. The role of exact exchange. J. Chem. Phys. 98 (1993) 5648-5652
31. Scott A., and Radom L. Harmonic vibrational frequencies: an evaluation of Hartree-Fock, Møller-Plesset, quadratic configuration interaction, density functional theory, and semiempirical scale factors. J. Phys. Chem. 100 (1996) 16502-16513
32. Boatz J., and Gordon M. Decomposition of normal-coordinate vibrational frequencies. J. Phys. Chem. 93 (1989) 1819-1826
33. A. Granovsky, PC GAMESS/Firefly Version 7.1.E, 2008, http://classic.chem.msu.su/gran/gamess/index.html.
34. Strachan C., Howell S., Rades Th., and Gordon K. A theoretical and spectroscopic study of carbamazepine polymorphs. J. Raman Spectrosc. 35 (2004) 401-408
35. Allen F. The Cambridge Structural Database: a quarter of a million crystal structures and rising. Acta Cryst. B 58 (2002) 380-388
36. Morsy M., Al-Khaldi A., and Suwaiyan A. Normal vibrational mode analysis and assignment of benzimidazole by ab initio and density functional calculations and polarized infrared and Raman spectroscopy. J. Phys. Chem. A 106 (2002) 2196-9203
37. Ayala A., Siesler H., and Cuffini S. Polymorphism incidence in commercial tablets of mebendazole: a vibrational spectroscopy investigation. J. Raman Spectrosc. 39 (2008) 1150-1157
38. Faber N., Duewer D., Choquette S., Green T., and Chesler N. Characterizing the uncertainty in near-infrared spectroscopic prediction of mixed-oxygenate concentrations in gasoline: sample-specific prediction intervals. Anal. Chem. 70 (1998) 2972-2982